Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Yu

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
JMIR Infodemiology|October 8, 2025
Physical Activity Misinformation on Social Media: Systematic ReviewD David Thomas, Linglin Xu, Brian Yu, et al.
Breast Cancer Research and Treatment|September 14, 2021
Evaluation of risk stratification using gene expression assays in patients with breast cancer receiving neoadjuvant chemotherapySung Jun Ma, Lucas M Serra, Brian Yu, et al.
Molecular and Cellular Biology|November 16, 2011
RBFOX2 promotes protein 4.1R exon 16 selection via U1 snRNP recruitmentShu-Ching Huang, Alexander C Ou, Jennie Park, et al.
American Journal of Surgery|November 21, 2024
A comparison of society guidelines in the management of gallbladder polypsLorena Garcia, Frances Dygean, Emily Bortree, et al.
BMC Biology|February 16, 2017
Long-term microfluidic tracking of coccoid cyanobacterial cells reveals robust control of division timingFeiqiao Brian Yu, Lisa Willis, Rosanna Man Wah Chau, et al.
American Journal of Perinatology|January 8, 2020
Ceftolozane/Tazobactam in Neonates and Young Infants: The Challenges of Collecting Pharmacokinetics and Safety Data in This Vulnerable Patient PopulationJocelyn Y Ang, Antonio Arrieta, John S Bradley, et al.
The Journal of Nutritional Biochemistry|May 13, 2026
High fat diet-induced diversity reduction in gut microbiota facilitates the development of systemic lupus erythematosusYu-Jih Su, Brian Yu-Ting Kuo, Leo Yen-Ting Lin, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2020
Outcomes in Participants with Renal Impairment from a Phase 3 Clinical Trial for Ceftolozane/Tazobactam Treatment of Nosocomial Pneumonia (ASPECT-NP)Jennifer A Huntington, Brian Yu, Linping Li, et al.
Bioinformatics (Oxford, England)|June 28, 2024
Reference-free structural variant detection in microbiomes via long-read co-assembly graphsKristen D Curry, Feiqiao Brian Yu, Summer E Vance, et al.
Clinical Pharmacokinetics|November 26, 2024
Pharmacokinetics of Tarlatamab, a Delta-Like Ligand-3 (DLL3) Targeted Half-Life Extended Bispecific T-Cell Engager (BiTE<sup>®</sup>) Immunotherapy in Adult Patients with Previously Treated Small-Cell Lung Cancer: Results from DeLLphi-300, a Phase I Multiple-Dose-Escalation StudyMukul Minocha, Corbin G Thompson, Alexis Murphy, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
JMIR Infodemiology|October 8, 2025
Physical Activity Misinformation on Social Media: Systematic ReviewD David Thomas, Linglin Xu, Brian Yu, et al.
Breast Cancer Research and Treatment|September 14, 2021
Evaluation of risk stratification using gene expression assays in patients with breast cancer receiving neoadjuvant chemotherapySung Jun Ma, Lucas M Serra, Brian Yu, et al.
Molecular and Cellular Biology|November 16, 2011
RBFOX2 promotes protein 4.1R exon 16 selection via U1 snRNP recruitmentShu-Ching Huang, Alexander C Ou, Jennie Park, et al.
American Journal of Surgery|November 21, 2024
A comparison of society guidelines in the management of gallbladder polypsLorena Garcia, Frances Dygean, Emily Bortree, et al.
BMC Biology|February 16, 2017
Long-term microfluidic tracking of coccoid cyanobacterial cells reveals robust control of division timingFeiqiao Brian Yu, Lisa Willis, Rosanna Man Wah Chau, et al.
American Journal of Perinatology|January 8, 2020
Ceftolozane/Tazobactam in Neonates and Young Infants: The Challenges of Collecting Pharmacokinetics and Safety Data in This Vulnerable Patient PopulationJocelyn Y Ang, Antonio Arrieta, John S Bradley, et al.
The Journal of Nutritional Biochemistry|May 13, 2026
High fat diet-induced diversity reduction in gut microbiota facilitates the development of systemic lupus erythematosusYu-Jih Su, Brian Yu-Ting Kuo, Leo Yen-Ting Lin, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2020
Outcomes in Participants with Renal Impairment from a Phase 3 Clinical Trial for Ceftolozane/Tazobactam Treatment of Nosocomial Pneumonia (ASPECT-NP)Jennifer A Huntington, Brian Yu, Linping Li, et al.
Bioinformatics (Oxford, England)|June 28, 2024
Reference-free structural variant detection in microbiomes via long-read co-assembly graphsKristen D Curry, Feiqiao Brian Yu, Summer E Vance, et al.
Clinical Pharmacokinetics|November 26, 2024
Pharmacokinetics of Tarlatamab, a Delta-Like Ligand-3 (DLL3) Targeted Half-Life Extended Bispecific T-Cell Engager (BiTE<sup>®</sup>) Immunotherapy in Adult Patients with Previously Treated Small-Cell Lung Cancer: Results from DeLLphi-300, a Phase I Multiple-Dose-Escalation StudyMukul Minocha, Corbin G Thompson, Alexis Murphy, et al.
Pageof 10